A Multicentre, Intra-patient Randomised Controlled Phase III Study to Confirm the Efficacy and Safety of DenovoSkin™, a Bilayer Engineered Collagen-based Skin Graft Composed of Autologous Fibroblasts and Keratinocytes, for the Treatment of Patients with Deep Partial and Full-thickness Burns
Latest Information Update: 26 Dec 2024
Price :
$35 *
At a glance
- Drugs EHSG-KF (Primary)
- Indications Burns
- Focus Registrational; Therapeutic Use
- Sponsors CUTISS
- 26 Dec 2024 New trial record